Evidence map›Paper›PMID 31519800›Full record

Trial reportJournal of nuclear medicine : official publication, Society of Nuclear Medicine2020

A Clinical Feasibility Study to Image Angiogenesis in Patients with Arteriovenous Malformations Using

Daphne Lobeek, Frédérique C M Bouwman, Erik H J G Aarntzen, Janneke D M Molkenboer-Kuenen, Uta E Flucke, Ha-Long Nguyen, Miikka Vikkula, Laurence M Boon, Willemijn Klein, Peter Laverman and 5 more

Open access · bronzeAbstract readClinical Trial
In one paragraph

Trial report in Journal of nuclear medicine : official publication, Society of Nuclear Medicine, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Development and Preclinical Evaluation ofJournal of medicinal chemistry · 2026
    Article
  2. Review
  3. Observational
  4. Review
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 6 institutions in 4 countries.

Daphne LobeekDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands daphne.lobeek@radboudumc.nl.
Frédérique C M BouwmanDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Erik H J G AarntzenDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Janneke D M Molkenboer-KuenenDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Uta E FluckeDepartment of Pathology, Radboud University Medical Center, Nijmegen, The Netherlands.
Ha-Long NguyenHuman Molecular Genetics, de Duve Institute, University of Louvain, Brussels, Belgium.
Miikka VikkulaHuman Molecular Genetics, de Duve Institute, University of Louvain, Brussels, Belgium.
Laurence M BoonHuman Molecular Genetics, de Duve Institute, University of Louvain, Brussels, Belgium.
Willemijn KleinDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Peter LavermanDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Wim J G OyenDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Otto C BoermanDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Samantha Y A TerryDepartment of Imaging Chemistry and Biology, School of Biomedical Engineering and Imaging Sciences, King's College London, London, United Kingdom.
Leo J Schultze KoolDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Mark RijpkemaDepartment of Radiology and Nuclear Medicine, Radboud University Medical Center, Nijmegen, The Netherlands.
Radboud University Medical Center · NLRadboud University Nijmegen · NLde Duve Institute · BECliniques Universitaires Saint-Luc · BEKing's College London · GBRijnstate Hospital · NL

Funding

Cancer Research UK A16463Wellcome Trust 203148
6 · The paper itself

Abstract

Arteriovenous malformations (AVMs) have an inherent capacity to form new blood vessels, resulting in excessive lesion growth, and this process is further triggered by the release of angiogenic factors.

Indexed as

OligopeptidesPositron Emission Tomography Computed TomographyAdultArteriovenous MalformationsFeasibility StudiesFemaleHumansMaleMiddle AgedNeovascularization, PathologicProspective StudiesProtein TransportYoung Adultarginyl-glycyl-aspartic acidOligopeptidesangiogenesisarteriovenous malformationintegrin αvβ3PET/CTRGD

Identifiers

PMID31519800
PMCPMC7100027
OpenAlexW2971015530

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.